Lotus Eye Hospital and Institute Limited

Lotus Eye Hospital and Institute Limited, a specialty eye care hospital, provides eye care and related services in India. The company offers ReLEx SMILE, a refractive lenticule extraction small incision lenticule extraction; touch-free laser; lasik eye surgery; Epi-LASIK, an epithelial laser in situ keratomileusis; Intralase, a blade-free technique to create the corneal flap; Zyoptix Supracor laser technology; robotic femto laser cataract surgery; phacoemulsification; paediatric eye care and squint surgery; and micro incision cataract surgery treatments.

Lotus Eye Hospital and Institute Limited (LOTUSEYE) is listed on the NSE in the Healthcare sector, Medical Care Facilities industry. The LOTUSEYE share price is ₹103.99 (-3.48% today), with a market capitalisation of ₹2B and a price-to-earnings (P/E) ratio of 1299.9. MarketRipple tracks the LOTUSEYE investment thesis, the ripple-chain impact of market events on Lotus Eye Hospital and Institute Limited, and the Healthcare sector outlook.

Frequently asked questions